An Epidemiological Assessment of the Stroke Burden in Hungary Using Data From the Global Burden of Disease Study (1990–2021)
Author(s)
Bettina Kovács, MSc1, Luca F. Kajos, MSc1, Dalma Pónusz-Kovács, MSc1, László Szapáry, MD, Ph.D., Habil2, Eszter Jozifek, MSc2, Patricia Szántóri, MSc3, Imre Boncz, MSc, PhD, MD1;
1University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Pécs, Hungary, 2University of Pécs, Clinical Centre, Department of Neurology, Pécs, Hungary, 3University of Pécs, Faculty of Health Sciences, Institute of Human Nutrition and Dietetics, Pécs, Hungary
1University of Pécs, Faculty of Health Sciences, Institute for Health Insurance, Pécs, Hungary, 2University of Pécs, Clinical Centre, Department of Neurology, Pécs, Hungary, 3University of Pécs, Faculty of Health Sciences, Institute of Human Nutrition and Dietetics, Pécs, Hungary
Presentation Documents
OBJECTIVES: Stroke is a major public health problem in Hungary, being one of the leading causes of death and disability. The aim of this study is to investigate the epidemiological indicators of stroke in Hungary using data from the Global Burden of Disease Study.
METHODS: For stroke, we examined prevalence and incidence data, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs) in Hungary between 1990 and 2021. The data were obtained from the Global Burden of Disease Study Institute for Health Metrics and Evaluation (GBD 2021, IHME) 2021 database. The analysis was conducted per 100,000 inhabitants, considering both sexes and all age groups.
RESULTS: In 1990, the prevalence of stroke in Hungary was 2.16%, which was 2,095.38 cases per 100,000 inhabitants. By 2021, the prevalence decreased to 1.75% (1,689.66 per 100,000). The age-standardised prevalence also decreased steadily over the same period (1990: 1.61%, 1,543.93 per 100,000; 2021: 1.00%, 936.66 per 100,000). The incidence also fell, from 0.09% (324.02 per 100,000) in 1990 to 0.06% (230.69 per 100,000) in 2021. In 1990, the DALY was 5,028.05 per 100,000 people, which was 10.71% of the total domestic DALY. By 2021, this figure had dropped significantly to 2,322.50 per 100,000 (5.04% of total domestic DALY). YLDs also declined, from 38,873.01 years (2.90% of total domestic YLDs) in 1990 to 29,509.62 years (2.16% of total domestic YLDs) in 2021.
CONCLUSIONS: The analysis indicates that stroke remains a significant public health challenge in Hungary, despite the observed positive trends. The decreasing prevalence and incidence rates, along with the reduced burden of disease, highlight the importance of continuously improving preventive measures and treatment protocols. These efforts are essential to further reduce the impact of stroke and enhance the population's quality of life.
METHODS: For stroke, we examined prevalence and incidence data, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs) in Hungary between 1990 and 2021. The data were obtained from the Global Burden of Disease Study Institute for Health Metrics and Evaluation (GBD 2021, IHME) 2021 database. The analysis was conducted per 100,000 inhabitants, considering both sexes and all age groups.
RESULTS: In 1990, the prevalence of stroke in Hungary was 2.16%, which was 2,095.38 cases per 100,000 inhabitants. By 2021, the prevalence decreased to 1.75% (1,689.66 per 100,000). The age-standardised prevalence also decreased steadily over the same period (1990: 1.61%, 1,543.93 per 100,000; 2021: 1.00%, 936.66 per 100,000). The incidence also fell, from 0.09% (324.02 per 100,000) in 1990 to 0.06% (230.69 per 100,000) in 2021. In 1990, the DALY was 5,028.05 per 100,000 people, which was 10.71% of the total domestic DALY. By 2021, this figure had dropped significantly to 2,322.50 per 100,000 (5.04% of total domestic DALY). YLDs also declined, from 38,873.01 years (2.90% of total domestic YLDs) in 1990 to 29,509.62 years (2.16% of total domestic YLDs) in 2021.
CONCLUSIONS: The analysis indicates that stroke remains a significant public health challenge in Hungary, despite the observed positive trends. The decreasing prevalence and incidence rates, along with the reduced burden of disease, highlight the importance of continuously improving preventive measures and treatment protocols. These efforts are essential to further reduce the impact of stroke and enhance the population's quality of life.
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
EPH123
Topic
Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
SDC: Cardiovascular Disorders (including MI, Stroke, Circulatory)